Anuh Pharma Limited (BOM:506260)
72.90
+1.58 (2.22%)
At close: Jan 22, 2026
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 7.29 billion as of January 23, 2026. Its market cap has decreased by -35.81% in one year.
Market Cap
7.29B
Enterprise Value
7.16B
Revenue
7.30B
Ranking
n/a
PE Ratio
18.82
Stock Price
72.90
Market Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 7.29B, an increase of 3,221.67%. That is a compound annual growth rate of 21.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.31B | -9.42% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 11.22B |
| Venus Remedies | 9.99B |
| Fermenta Biotech | 9.56B |
| Lincoln Pharmaceuticals | 9.07B |
| Bharat Parenterals | 7.68B |
| Accent Microcell | 7.13B |
| Fredun Pharmaceuticals | 7.10B |
| Kopran | 6.55B |